WINT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Windtree Therapeutics Inc

NASDAQ | WINT

0.13

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$4.40M

Market Cap

0.0024

P/E Ratio

62.6

EPS

$60.00

52 Week High

$0.06

52 Week Low

HEALTHCARE

Sector

WINT Chart

Recent Chart
Price Action

WINT Technicals

Tags:

WINT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$84K
Total Revenue $0
Cost Of Revenue $84K
Costof Goods And Services Sold $84K
Operating Income -$25M
Selling General And Administrative $8.7M
Research And Development $16M
Operating Expenses $25M
Investment Income Net -
Net Interest Income -$165K
Interest Income $70K
Interest Expense $235K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $84K
Income Before Tax -$1.8M
Income Tax Expense $3.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$1.8M
Comprehensive Income Net Of Tax -
Ebit -$1.6M
Ebitda -$1.5M
Net Income -$5.5M

Revenue & Profitability

Earnings Performance

WINT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $28M
Total Current Assets $2.6M
Cash And Cash Equivalents At Carrying Value $1.8M
Cash And Short Term Investments $1.8M
Inventory -
Current Net Receivables -
Total Non Current Assets $25M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $24M
Intangible Assets Excluding Goodwill $24M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $795K
Other Non Current Assets -
Total Liabilities $18M
Total Current Liabilities $5.7M
Current Accounts Payable $1.9M
Deferred Revenue -
Current Debt -
Short Term Debt $841K
Total Non Current Liabilities $12M
Capital Lease Obligations $1.2M
Long Term Debt -
Current Long Term Debt $661K
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.8M
Other Current Liabilities $2.7M
Other Non Current Liabilities $3.8M
Total Shareholder Equity $10M
Treasury Stock -
Retained Earnings -$847M
Common Stock $305K
Common Stock Shares Outstanding $53K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$15M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $84K
Capital Expenditures $12K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$12K
Cashflow From Financing $13M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $657K
Dividend Payout Common Stock $657K
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1.9M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$1.8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$84K
Total Revenue $0
Cost Of Revenue $84K
Costof Goods And Services Sold $84K
Operating Income -$25M
Selling General And Administrative $8.7M
Research And Development $16M
Operating Expenses $25M
Investment Income Net -
Net Interest Income -$165K
Interest Income $70K
Interest Expense $235K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $84K
Income Before Tax -$1.8M
Income Tax Expense $3.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$1.8M
Comprehensive Income Net Of Tax -
Ebit -$1.6M
Ebitda -$1.5M
Net Income -$5.5M

WINT Profile

Windtree Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Windtree Therapeutics, Inc. is a clinical-stage biotechnology and medical device company dedicated to advancing innovative therapies for acute pulmonary and cardiovascular diseases. With a strong emphasis on addressing unmet medical needs, the company is advancing its proprietary product candidates through various stages of clinical development. Windtree's unique approach combines advanced therapeutic modalities and devices, positioning it for potential significant impact in the healthcare market. The company's commitment to improving patient outcomes underscores its strategic focus on delivering life-changing treatments.

VHAI
0.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
YDKG
-49.73%
$0.09
NVDA
+1.10%
$181.81
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
BBD
+1.87%
$3.26
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
DFLI
-32.48%
$1.33
AMD
-1.69%
$234.56
AXDX
-61.36%
$0.03
ETHD
+5.82%
$4.00
GDXD
-10.23%
$0.60
RIG
-2.41%
$3.23
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
CLF
-2.79%
$13.56
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
AMC
-2.48%
$2.75
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
ABAT
-36.64%
$5.67
QS
-13.38%
$15.46
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
NAK
-15.15%
$2.24
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
CIFR
-10.98%
$18.72
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
UUUU
-13.20%
$21.69
CRML
-14.52%
$19.42
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.83%
$47.64
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
HIMS
-5.75%
$59.15
ADD
-25.47%
$0.05
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
SLNH
-2.33%
$4.19
JOBY
-8.69%
$16.07
CRWV
+1.79%
$141.74
TOVX
-48.67%
$0.43
IONQ
-9.41%
$65.59
SATL
-29.71%
$2.91
SRM
+53.27%
$10.30
VHAI
0.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
YDKG
-49.73%
$0.09
NVDA
+1.10%
$181.81
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
BBD
+1.87%
$3.26
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
DFLI
-32.48%
$1.33
AMD
-1.69%
$234.56
AXDX
-61.36%
$0.03
ETHD
+5.82%
$4.00
GDXD
-10.23%
$0.60
RIG
-2.41%
$3.23
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
CLF
-2.79%
$13.56
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
AMC
-2.48%
$2.75
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
ABAT
-36.64%
$5.67
QS
-13.38%
$15.46
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
NAK
-15.15%
$2.24
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
CIFR
-10.98%
$18.72
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
UUUU
-13.20%
$21.69
CRML
-14.52%
$19.42
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.83%
$47.64
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
HIMS
-5.75%
$59.15
ADD
-25.47%
$0.05
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
SLNH
-2.33%
$4.19
JOBY
-8.69%
$16.07
CRWV
+1.79%
$141.74
TOVX
-48.67%
$0.43
IONQ
-9.41%
$65.59
SATL
-29.71%
$2.91
SRM
+53.27%
$10.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.